Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome

The five-year survival rate of lung cancer patients is very low, mainly because most newly diagnosed patients present with locally advanced or metastatic disease. Therefore, early diagnosis is key to the successful treatment and management of lung cancer. Unfortunately, early detection methods of lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Haince, Jean-François, Joubert, Philippe, Bach, Horacio, Ahmed Bux, Rashid, Tappia, Paramjit S., Ramjiawan, Bram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835988/
https://www.ncbi.nlm.nih.gov/pubmed/35163138
http://dx.doi.org/10.3390/ijms23031215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835988/
https://www.ncbi.nlm.nih.gov/pubmed/35163138
http://dx.doi.org/10.3390/ijms23031215

Ejemplares similares